Medcan Australia
PrivateLast Round
Early Funding
Jan 10, 2022
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Medcan Australia is a pharmaceutical and biotechnology company that cultivates, produces, and manufactures medicinal cannabis products for clinical and individual patient use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medcan Australia Comparables
Compare Medcan Australia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Australian Natural Therapeutics Group | 89% | |
| Cymra Life Sciences | 86% | |
| Cann Group Ltd | 86% |
Medcan Australia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 10, 2022 | ||||
| Seed | Nov 1, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 17% QoQ, from 29 to 34 employees.
- May 17, 2026
Monthly visitors grew 69% MoM, reaching 2.3K.
Medcan Australia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medcan Australia's valuation, stock price, and market status.
Is Medcan Australia a public or private company?
Medcan Australia is a private company.
What is the current stock price of Medcan Australia?
Medcan Australia is a private company with no public stock price. No recent secondary market data is available.
How much is Medcan Australia worth (valuation)?
Valuation information for Medcan Australia is not publicly available.
Can I buy Medcan Australia stock?
Medcan Australia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medcan Australia's last funding round?
Medcan Australia's most recent funding round was Early Funding on January 10, 2022.
Who are the main investors in Medcan Australia?
Investor information for Medcan Australia is not publicly disclosed.
Will Medcan Australia IPO soon?
No public IPO plans have been announced for Medcan Australia.
How can I track Medcan Australia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medcan Australia's secondary market activity and sign up for updates.